Moreover, mice that received a secondary transplantation of NEAT1−/− bone marrow cells developed AML and died even earlier compared to mice transplanted with wild‐type or NEAT1_1 rescued‐bone marrow cells (Figure 3M). This evidence concerns the gene NEAT1 and acute myeloid leukemia.